Cost-effectiveness analysis of short-duration dual antiplatelet therapy with newer drug-eluting stent platforms versus longer-duration dual antiplatelet therapy with a second-generation drug-eluting stent in elective percutaneous coronary intervention.

Galper BZ, Reynolds MR, Garg P, Secemsky EA, Valsdottir LR, Cohen DJ, Yeh RW. Cost-effectiveness analysis of short-duration dual antiplatelet therapy with newer drug-eluting stent platforms versus longer-duration dual antiplatelet therapy with a second-generation drug-eluting stent in elective percutaneous coronary intervention. Coron Artery Dis. 2019 05; 30(3):177-182.

View in: PubMed

subject areas

Clinical Decision-Making
Coronary Artery Disease
Cost-Benefit Analysis
Drug Administration Schedule
Drug Costs
Drug Therapy, Combination
Drug-Eluting Stents
Hemorrhage
Hospital Costs
Humans
Markov Chains
Models, Economic
Percutaneous Coronary Intervention
Platelet Aggregation Inhibitors
Prosthesis Design
Quality of Life
Quality-Adjusted Life Years
Risk Assessment
Risk Factors
Time Factors
Treatment Outcome

authors with profiles

Matthew R Reynolds MD, MSc